Trimetazidine Hydrochloride 80 mg ER is used as an adjunct therapy in the management of chronic stable angina pectoris. It works by improving the energy metabolism of heart cells during ischemia, helping the heart function more efficiently without affecting heart rate or blood pressure. The extended-release (ER) formulation provides sustained therapeutic effect with once-daily dosing, improving patient compliance.
